152 related articles for article (PubMed ID: 38673313)
21. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.
Pinsky PF; Church TR; Izmirlian G; Kramer BS
Cancer; 2013 Nov; 119(22):3976-83. PubMed ID: 24037918
[TBL] [Abstract][Full Text] [Related]
22. Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study.
Kim IA; Lee JS; Kim HJ; Kim WS; Lee KY
BMC Cancer; 2018 Jul; 18(1):768. PubMed ID: 30055587
[TBL] [Abstract][Full Text] [Related]
23. Impact of current versus former smoking status on the outcomes of non-metastatic non-small cell lung cancer treated with upfront surgery; findings from the National Lung Screening Trial.
Abdel-Rahman O
Expert Rev Respir Med; 2019 Jun; 13(6):585-591. PubMed ID: 31055993
[No Abstract] [Full Text] [Related]
24. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
[TBL] [Abstract][Full Text] [Related]
26. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model.
Veronesi G; Maisonneuve P; Rampinelli C; Bertolotti R; Petrella F; Spaggiari L; Bellomi M
Lung Cancer; 2013 Dec; 82(3):426-30. PubMed ID: 24099665
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.
Ma Z; Zhang Y; Deng C; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e73-e85. PubMed ID: 32739163
[TBL] [Abstract][Full Text] [Related]
28. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
[TBL] [Abstract][Full Text] [Related]
29. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
30. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force.
Slatore CG; Baumann C; Pappas M; Humphrey LL
Ann Am Thorac Soc; 2014 May; 11(4):619-27. PubMed ID: 24701999
[TBL] [Abstract][Full Text] [Related]
31. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
33. Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.
Kim HY; Jung KW; Lim KY; Lee SH; Jun JK; Kim J; Hwangbo B; Lee JS
Cancer Res Treat; 2018 Jul; 50(3):748-756. PubMed ID: 28724283
[TBL] [Abstract][Full Text] [Related]
34. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
[TBL] [Abstract][Full Text] [Related]
35. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.
Clément-Duchêne C; Stock S; Xu X; Chang ET; Gomez SL; West DW; Wakelee HA; Gould MK
Ann Am Thorac Soc; 2016 Jan; 13(1):58-66. PubMed ID: 26730864
[TBL] [Abstract][Full Text] [Related]
36. Nicotine dependence as an independent risk factor for atherosclerosis in the National Lung Screening Trial.
Zhu J; Nelson K; Toth J; Muscat JE
BMC Public Health; 2019 Jan; 19(1):103. PubMed ID: 30669994
[TBL] [Abstract][Full Text] [Related]
37. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
38. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.
Sohn HS; Kwon JW; Shin S; Kim HS; Kim H
J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of CT screening for lung cancer in never-smokers: analysis of Japanese cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):426-32. PubMed ID: 21663997
[TBL] [Abstract][Full Text] [Related]
40. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
